Journal of Jilin University Medicine Edition ›› 2017, Vol. 43 ›› Issue (04): 757-761.doi: 10.13481/j.1671-587x.20170419

Previous Articles     Next Articles

Significance of anti-nucleosome antibody,anti-C1q antibody and anti-double stranded DNA antibody in diagnosis of lupus nephritis

YIN Fangrui1,2, PANG Chunyan1,2, LYU Fengfeng1,2, ZHANG Wenlan1, ZHAO Jianbo1, WANG Yongfu1,2   

  1. 1. Department of Rheumatology, First AffiliatedHospital, Baotou Medical College, Institute of Immunology and Rheumatology, Baotou Medical College, Baotou 014010, China;
    2. Inner Mongolia Key Laboratory of Autoimmunity, Baotou 014010, China
  • Received:2016-12-04 Online:2017-07-28 Published:2017-08-01

Abstract: Objective: To investigate the clinical and laboratory characteristics of lupus nephritis(LN) patients by detecting the anti-nucleosome antibodies, anti-C1q antibodies and anti-double stranded antibodies(anti-ds DNA), and to clarify the risk factors of LN in the patients with systemic lupus erythematosus(SLE),and the significance of three kinds of antibodies in diagnosis of LN.Methods: A total of 120 SLE patients were selected and divided into LN group(n=60) and non-LN group(n=60).The ANAS data of 120 patients were retrospectively analyzed,the levels of anti-C1q antibodies were measured.The clinical symptoms and laboratory data of the patients with positive anti-dsDNA, -nucleosome and -C1q antibodies (3-pos group)and negative three kinds of antibodies(non 3-pos group) were analyzed in LN group.Results: The positive rate of anti-C1q antibody of the patients in LN group (40.00%) was higher than that in non-LN group (21.67%) (χ2=4.728, P=0.03).The positive rate of anti-dsDNA antibody in LN group was 66.67%, and it was 46.67% in non-LN group; the positive rates of the patients had significant difference between two groups (χ2=4.887, P=0.027). The positive rate of anti-nucleosome antibody in LN group was 58.33%, and it was 40.00% in non-LN group; the positive rates of the patients had significant difference between two groups (χ2=4.034, P=0.045).The positive rates of U1-snRNP, SmD1 and other antibodies Jo-1, SSA/Ro60kD, SSA/Ro52kD, SSB, ScL-70, CENP-B,and P0 had no significant differences between two groups(P>0.05). The levels of C3 and C4 and hemoglobinin of the patients in 3-pos group were higher than those innon 3-pos group (P<0.05);the age,the levels of immunoglobulin protein and C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), white blood cell (WBC) and platelet had no statistically significant differences between 3-pos and non 3-pos groups(P>0.05).The clinical symptoms were not statistically significant in 3-pos and non 3-pos groups (P>0.05).Conclusion: The anti-nucleosome, anti-C1q and anti-dsDNA antibodies are the risk factors of SLE complicated with LN;the positive antibodies can improve the diagnostic rate of LN.The 3-pos patients have more severe damage in complements and blood system with higher renal disease activities.

Key words: anti-nucleosome antibody, lupus nephritis, anti-C1q antibody, anti-double stranded DNA antibody

CLC Number: 

  • R593.24